![Nigel Theobald](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nigel Theobald
Nessuna posizione attualmente
Patrimonio netto: 140 945 $ in data 30/09/2026
Profilo
Nigel James Theobald is the founder of Abaco Capital Plc, founded in 2009.
Mr. Theobald was the founder of N4 Pharma Plc, founded in 2014, and held the title of Chief Executive Officer & Executive Director from 2017 to 2026.
Mr. Theobald was the founder of N4 Pharma UK Ltd., founded in 2014, and held the title of Chief Executive Officer.
Mr. Theobald was a Non-Executive Director at Medherant Ltd. Mr. Theobald was Head-Healthcare Brands at Boots Group Plc.
Mr. Theobald completed undergraduate education at The University of Southampton.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 23/04/2025 | 16.981.319 ( 0,96% ) | 140 945 $ | 30/09/2026 |
Precedenti posizioni note di Nigel Theobald
| Società | Posizione | Fine |
|---|---|---|
| THALIA THERAPEUTICS PLC | Fondatore | 24/02/2026 |
Boots Group Plc
 Boots Group Plc Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical and consumer products | Corporate Officer/Principal | - |
Medherant Ltd.
 Medherant Ltd. Pharmaceuticals: MajorHealth Technology Develops transdermal drug delivery patches | Direttore/Membro del Consiglio | - |
N4 Pharma Ltd.
 N4 Pharma Ltd. Pharmaceuticals: GenericHealth Technology Operates as a drug reformulation company | Amministratore Delegato | - |
| ABACO CAPITAL PLC | Fondatore | - |
Formazione di Nigel Theobald
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
12
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Boots Group Plc
Boots Group Plc Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical and consumer products | Health Technology |
The University of Southampton
 The University of Southampton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abaco Capital Plc
 Abaco Capital Plc Financial ConglomeratesFinance Operates as a shell company with no operations | Finance |
N4 Pharma Ltd.
N4 Pharma Ltd. Pharmaceuticals: GenericHealth Technology Operates as a drug reformulation company | Health Technology |
Medherant Ltd.
Medherant Ltd. Pharmaceuticals: MajorHealth Technology Develops transdermal drug delivery patches | Health Technology |
N4 Pharma Plc
 N4 Pharma Plc BiotechnologyHealth Technology Provides specialist pharmaceutical services that reformulates existing drugs and vaccines to improve their performance | Health Technology |
